TE_10721
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | ENSG00000250735 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 228.42 |
| Counts of samples | TCGA_tumor:607; TCGA_normal:0; GTEx:2 |
| TSS | chr4(+):75401197 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_10721.1 | ENSG00000250735 | Annoated | Non-coding | Non-coding | chr4(+):75401198,75401292,75422054,75422192,75422579,75422599 |
| teRNA_10721.2 | ENSG00000250735 | Annoated | Non-coding | Non-coding | chr4(+):75401198,75401292,75407895,75408012,75422054,75422192,75422579,75422599 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
